Israeli mask which ‘gives 99 percent virus safety’ gets European lab approval

The latest Jewish News

Read this week’s digital edition

Click Here

Israeli mask which ‘gives 99 percent virus safety’ gets European lab approval

Sonovia's state-of-the-art tech has been verified by an Italian pharmaceutical firm, with its makers saying it can protect from Covid, flu and acne-causing bacteria linked to masks

Models wearing the SonoMask
Models wearing the SonoMask

An Israeli start-up behind an anti-viral mask shown to neutralise 99 percent of coronavirus has received European verification.

Special coating on Sonovia’s state-of-the-art technology has been verified by VisMederi Textyle in Italy, a pharmaceutical company based in Tuscany, with the same testing showing it is equally effective at neutralising flu, as well as Covid-19.

The mask, which the firm says can reduce the spread of diseases caused by bacteria, fungi and viruses, even after many laundry cycles, was awarded a €2.4 million grant (£2.2m)  from the European Commission last year.

In March 2021, an Israeli facility accredited by the FDA (American Food and Drug Administration), found the SonoMask also eliminates 99 percent of acne-causing bacteria associated with masks (Maskne), which effects 50 million people a year.

Sonovia, which has now sold over 250,000 masks to over 100 counties – including in the UK where more than 11,000 have been purchased – said it is conducting trials to expand the use of its technology – as it looks to roll out masks more widely, as many countries continue to reopen from coronavirus lockdowns.


Dr. Aaron Garzon, Sonovia’s VP of R&D, said: “We are delighted with the results, but we are not stunned. As in all tests we have conducted so far, we once again our technology is showing fantastic efficiency against viruses and bacteria. Our cutting-edge technology will be the textile world’s insurance certificate to avoid the spread of future epidemics and viruses. I have no doubt that our technology will be able to eliminate the threat of any virus or bacteria that comes in contact with it, and the results will be similar. I applaud our scientific team for the long way we have come and look forward to expanding the technology in commercial applications.”

Sonovia listed on the Tel Aviv stock exchange in December 2020 and has since doubled in value to more than £30m. This comes after  Sonovia the Weipu Jishu lab in Shanghai found the fabric used in the masks “neutralised more than 90 percent of the coronavirus to which it was exposed”, as reported in June 2020.





Help perform the greatest mitzvah: save a life

While life in Israel has returned to normal and hopes are high that Britain is set for a summer without restrictions thanks to vaccines, for billions around the world there is no such imminent light at the end of the tunnel. In the majority of countries around the globe, particularly the poorest, the vaccine rollout has barely kicked off.

That's why Jewish News, the leading source of news and opinion for the entire UK community, is throwing its full weight behind UNICEF’s VaccinAid campaign by using this platform usually reserved for encouraging donations towards our own journalism to instead urge our readers around the globe to perform the greatest mitzvah: saving a life.

We have never before done this for any charity fundraiser but it's hard to recall a campaign that affects so many people, and indeed an entire planet aching for a return to normality. Just like the Chief Rabbi and Rachel Riley, we hope to boost the mission to deliver two billion vaccines, 165 million treatments and 900 million test kits around the world by the end of this year.

Please donate as much as you can, in the spirit of the Talmudic sages: “to save one life is to save the world entire”

read more: